TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Arcedi Biotech ApS
Closing information (x1000 DKK)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
0
|
0 | |
| Earnings before taxes |
-50,714
|
-42,216 | |
| Total assets |
135,920
|
137,153 | |
| Current assets |
12,294
|
12,038 | |
| Current liabilities |
4,670
|
7,185 | |
| Equity capital |
-127,758
|
-85,797 | |
| - share capital |
80
|
80 | |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
-94.0%
|
-62.6% | |
| Turnover per employee |
0
|
0 | |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
263.3%
|
167.5% | |
| Return on equity (ROE) |
39.7%
|
49.2% | |
| Change turnover |
0
|
0 | |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.